/Investor DB

Leafy Tunnel

Venture capital

London · Seed–Series A · 2 people tracked

Find your way into Leafy Tunnel

Each arrow is one introduction. Sign up to fill in the first one.

29 people can intro you to Nikolay

Ask Joe Petrusic to introduce you to Nikolay Tretiyakov

You →Joe · together at Impact Investing Ghana →Nikolay

Sign up to find every way you can get introduced to Leafy Tunnel

  • Your email: who you already know at Leafy Tunnel, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Leafy Tunnel team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Leafy Tunnel focuses on backing companies developing alternative medicines aimed at addressing mental health issues and pain-related disorders. Its stated investment interest centers on therapeutic approaches in these areas.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series A
HQ
London, GB
Instruments
Equity
Founded
2021
Tracked investments
11
IPOs
1

Team · 2 people

from the firm's website

What they invest in

from 10 of 11 portfolio companies

Biotech ×7Healthtech ×5Digital Health ×4Medical Devices ×4Mental Health ×4Deep Tech ×3AI & Machine Learning ×2AgTech ×1

HQs:United Kingdom×2United States×2Canada×1Denmark×1

Investments · 11 tracked

founders shown can be your intro path

By year:2024 · 22021 · 13 dated

AtaiBeckleyatai.lifeNASDAQ: ATAI

AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions.

BiotechDeep TechDigital HealthHealthtechMedical DevicesMental Health

Srinivas Rao(Co-Founder and Chief Executive Officer)inChristian Angermayer(Founder and Chairman of the Board)

Co-investorsAble PartnersAlpha Wave GlobalAtaiBeckleyCatalio Capital Management, LPFJ LabsFuture Ventures+6 more

Beckley Psytechbeckleypsytech.com

AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.

BiotechMedical DevicesMental Health

Christian AngermayerCosmo Feilding Mellen(Founder)inSrinivas Rao

Co-investorsFJ LabsIter InvestmentsNegev CapitalNoeticPalo Santo VCRedbus Ventures+2 more

Ceretypeceretype.cominJan 2024 · $2M

Ceretype develops brain imaging and analysis tools that provide insights into brain circuitry for therapeutic development and clinical care of psychiatric and neurological disorders.

AI & Machine LearningBiotechDigital HealthMedical Devices

Emily Stern(CEO)inRoni Setton(Scientific Director)in

BoardDavid Silbersweig(SAB Chair)

Co-investorsJLS

Iuvo Therapeuticsiuvo-therapeutics.com

IUVO is a cannabis company that partners with craft cultivators, including Organnicraft, a British Columbia-based grower of premium cannabis strains from the legacy markets of California and BC.

AgTechConsumer

Lykos Therapeutics fka MAPS PBClykospbc.comin𝕏

Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder.

BiotechDeep TechMental Health

Co-investorsJourneyOne VenturesLauder PartnersSolari CapitalWGD Capital, L.P.XEIA Venture Partners

mayamayahealth.com

Maya Health (Naitur) builds compliance-focused AI automation for independent health and wellness practices, covering intake-to-EMR sync, follow-ups, lab result delivery, rating-scale scoring, and safety escalation.

AI & Machine LearningDigital HealthHealthtech

Co-investorsInnovating CapitalPsyMed Ventures

Prohibition Partnersprohibitionpartners.comin𝕏

Prohibition Partners operates a B2B discovery platform and ecosystem for the legal cannabis industry, offering conferences, market intelligence content, digital media publishing, and a marketplace for cannabis businesses to transact products and services.

B2B MarketplacesCrypto & Web3Data & InfrastructureFintechMedia & EntertainmentLondon, GB

Stephen Murphy(Founder)in

Co-investorsArtemis Growth Partners

Tactogentactogen.comin𝕏

Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds.

BiotechDeep TechHealthtech

Matthew Baggott(CEO)in

Co-investorsNoeticPsyMed Ventures10X CapitalPalo Santo VCWefunder

Tetra Pharmtetra-pharm.comin

Tetra Pharm develops next-generation drugs targeting neurological disorders including chronic pain, Alzheimer's, and obesity.

BiotechDigital HealthHealthtechMedical DevicesMental HealthCopenhagen, DK

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Ceretype NeuromedicineMaya PBC

Exits · 1

1 IPOs

AtaiBeckleyNASDAQ: ATAI

Principals & officers · per Companies House

what is this? ⓘ
Ownership & control

Nikolay Tretiyakov — 75–100% of shares, 75–100% of voting rights, right to appoint and remove directors

Frequently asked questions

How many investments has Leafy Tunnel made?
Leafy Tunnel has 11 tracked investments, 1 of which have exited.
What stage does Leafy Tunnel invest at?
Leafy Tunnel invests at the Seed, Series A stages.
What sectors does Leafy Tunnel focus on?
Leafy Tunnel focuses on Biotech, Healthtech, Medical Devices, Mental Health, Wellness & Fitness.
Where is Leafy Tunnel located?
Leafy Tunnel is headquartered in London, GB.
Who does Leafy Tunnel co-invest with?
Leafy Tunnel most often shares deals with FJ Labs, Noetic, PsyMed Ventures, among 25 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Professionally Cannabis | Bek Muslimov & Nikolay Tretiyakov, Co-Founders of Leafy Tunnel | EP62

Global Cannabis Intelligence · Nikolay Tretiyakov

Similar investors

Featured in lists